EP191: Telehealth Industry Updates, With Nate Lacktman, Partner at Foley & Lardner LLP and Chair of the Telemedicine Industry Team
July 26, 2018
191
36:25

EP191: Telehealth Industry Updates, With Nate Lacktman, Partner at Foley & Lardner LLP and Chair of the Telemedicine Industry Team

Nathaniel (Nate) Lacktman is a partner with the law firm Foley & Lardner LLP, where he is the chair of the firm’s Telemedicine Industry Team. He advises health care providers and technology companies on business arrangements, compliance, and corporate matters, with particular attention to telehealth, digital health, virtual care, and health innovation. Working with hospitals, entrepreneurs, and start-ups to build telemedicine arrangements across the United States and internationally, his practice emphasizes strategic counseling, creative business modeling, and fresh approaches to realize clients' ambitious and innovative goals.


01:42 How Nate defines telemedicine.
02:25 Asynchronous vs synchronous debate.
02:46 The established gold standard of telemedicine.
03:38 Radiology as a prime example of asynchronous medicine.
05:30 Asynchronous precedent for reimbursement.
05:55 Interesting use cases of telemedicine.
08:20 More complex examples of asynchronous medicine use cases.
09:40 Distinguishing direct-to-consumer telemedicine from institutional telemedicine contracts.
10:08 Remote interpretive reads.
12:17 “No one at a health plan wants their members to have untreated diabetes.”
12:21 “It is their job to help provide access and quality care to their members.”
13:26 Fee-for-service payments vs value-based payments in telemedicine.
16:13 A poorly written state telemedicine law example.
21:22 “The shift from fee-for-service to risk-based care has not happened as fast as anyone anticipated.”
23:33 The fears in telemedicine.
25:55 Making entrepreneurial clients aware of medical laws, terms, and concepts.
27:42 Anti-kickback laws and how they apply to telemedicine.
30:39 What’s happening in Medicare with telemedicine.
33:35 Telemedicine prescribing of controlled substances.
35:21 Go to foley.com/telemedicine or healthcarelawtoday.com to learn more.

healthcare,marketing,telehealth,telemedicine,foley & lardner llp,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuide, Ann Kempski, Spencer Allen, Scott Tromanhauser, Steven Elkins, Matthew Bunte, Lori Smith, Dr. Scott Conard, Vivian Ho and Casey Cormier

Recent Episodes

EP536: Operationalizing the Architecture of Primary Care Patient Experience, With Rebecca Andrews, MD
Relentless Health ValueNovember 04, 2026
536
37:5134.64 MB

EP536: Operationalizing the Architecture of Primary Care Patient Experience, With Rebecca Andrews, MD

Listen On Your Favorite App Stacey: If you are a plan sponsor thinking about, for example, primary care as a way to optimize healthcare spend, do know that any given plan sponsor will really only get maximum possible benefit from an investment in primary care, advanced primary care, when and only wh...

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone
Relentless Health ValueOctober 28, 2026
535
37:1834.15 MB

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone

LIsten on Your Favorite App On episode 532 a few weeks ago, Chris Klomp from HHS was talking about ER (emergency room) usage as a signal, not just a statistic. If too many folks show up in the ER, consider this a signal that there's something missing. It means a patient who doesn't have access to pr...

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson
Relentless Health ValueOctober 21, 202608:538.13 MB

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson

Listen On Your Favorite App Here's a question I have heard more than once: What is a practical, speedy way to assess whether a TPA (third-party administrator) is truly independent and willing to protect the plan's interests, this plan sponsor's interests, versus being captive to, for example, networ...

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio
Relentless Health ValueOctober 14, 2026
533
37:1334.07 MB

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio

Hello, all you Relentless Tribe members. Thanks for hanging with me today to talk about a bunch of things. One of them being what exactly are level-funded plans, and what are the upsides, and then what are the risks? Because here's the thing. I was talking to an employer the other day, an employer w...

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp
Relentless Health ValueOctober 07, 2026
532
37:2034.17 MB

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp

Listen on Your Favorite App Today we are dipping into the archives for an essential replay from 2016, one decade ago, featuring Chris Klomp back when he served as CEO of a company called Collective Medical. With the nomination of Chris Klomp to serve as deputy secretary of the Department of Health a...

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson
Relentless Health ValueSeptember 30, 2026
531
38:0634.88 MB

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson

Listen on Your Favorite App Today, Evan Anderson and I are talking about carrier networks, how they started, how it's going. Because irrespective of whatever the plan was at the very beginning, any given network, especially talking about the big status quo networks, has evolved into what I'll call a...

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh
Relentless Health ValueSeptember 23, 2026
530
37:4534.56 MB

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh

Listen on Your Favorite App Hello, all you Relentless Tribe members. Thanks for hanging with me this week. When a self-insured plan sponsor sees an infusion claim hit their high-cost case report, and a lot of these infusions are really expensive, so many of them hit the high-cost claim report. For a...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.